NCCN Guidelines Insights: Breast Cancer, Version 3.2018

Authors :: Matthew P, Goetz
William J, Gradishar
Benjamin O, Anderson
Jame, Abraham
Rebecca, Aft
Kimberly H, Allison
Sarah L, Blair
Harold J, Burstein
Chau, Dang
Anthony D, Elias
William B, Farrar
Sharon H, Giordano
Lori J, Goldstein
Steven J, Isakoff
Janice, Lyons
P Kelly, Marcom
Ingrid A, Mayer
Meena S, Moran
Joanne, Mortimer
Ruth M, O'Regan
Sameer A, Patel
Lori J, Pierce
Elizabeth C, Reed
Hope S, Rugo
Amy, Sitapati
Karen Lisa, Smith
Mary Lou, Smith
Hatem, Soliman
Melinda L, Telli
John H, Ward
Jessica S, Young
Dorothy A, Shead
Rashmi, Kumar
Source :: Journal of the National Comprehensive Cancer Network : JNCCN. 17(2)
Publication Year :: 2019
Abstract: These NCCN Guidelines Insights highlight the updated recommendations for use of multigene assays to guide decisions on adjuvant systemic chemotherapy therapy for women with hormone receptor-positive, HER2-negative early-stage invasive breast cancer. This report summarizes these updates and discusses the rationale behind them.

Tools